Skip to main content

Nebulizer Market Worth USD 1,778.8 Million at 8.1% CAGR; Large Medical Device Manufacturers Such as Philips and Omron to Develop Products to Deal with the COVID-19 Outbreak: Fortune Business Insights™

Pune, Sept. 14, 2020 (GLOBE NEWSWIRE) — Global Nebulizer market size is projected to reach USD 1,778.8 million by 2027, exhibiting a CAGR of 8.1% during the forecast period. Increasing prevalence of respiratory disorders around the world will be the prime growth propeller for this market.The World Health Organization (WHO) states that respiratory diseases are the foremost cause of death and disability worldwide. According to its estimates, chronic obstructive pulmonary disorder (COPD) afflicts around 65 million and kills 3 million people every year. Similarly, pneumonia also kills millions of people annually and is the leading cause of mortality among children under 5 years of age. Furthermore, WHO data indicates that lung cancer is the deadliest cancer, killing 1.6 million people every year. Nebulizer play a key role in managing these chronic and potentially fatal lung disorders and as the incidence of these disorders grows, the demand for Nebulizer will continue to surge.The report states that the market value was at USD 909.7 million in 2019. Its other highlights include:Valuable insights into the key market drivers, trends, and restraints;Exhaustive analysis of the upcoming market opportunities;In-depth examination of the impact of the COVID-19 outbreak on the market; andComprehensive study of the regional prospects and competitive dynamics influencing the market.
Request a Sample Copy of the Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/nebulizers-market-100707
Market OpportunityRapid Transmission of the COVID-19 Infection to Create Immediate Growth OpportunitiesThe SARS-CoV-2 infection attacks the respiratory tract and lungs, causing shortness of breath, acute breathing problems, and pneumonia, along with a persistent fever and cough. People with preexisting lung disorders such as asthma are at high risk of contracting the COVID-19 infection. According to the Centers for Disease Control and Prevention (CDC), asthma patients are highly recommended to carry inhalers or portable Nebulizer with them as these devices can efficiently open the lungs and allow them to function normally.In this scenario, the uptake of inhalable drug delivery devices is likely to spike and favor the Nebulizer market growth. The only worry with these devices, as pointed out by the Asthma and Allergy Foundation of America, is their potential to transmit the infection among patients as well as healthcare workers, especially in healthcare facilities. If this issue is addressed, players can capitalize on the current pandemic and expand their presence in the market.  The emergence of COVID-19 has brought the world to a standstill. We understand that this health crisis has brought an unprecedented impact on businesses across industries. However, this too shall pass. Rising support from governments and several companies can help in the fight against this highly contagious disease. There are some industries that are struggling and some are thriving. Overall, almost every sector is anticipated to be impacted by the pandemic.We are taking continuous efforts to help your business sustain and grow during COVID-19 pandemics. Based on our experience and expertise, we will offer you an impact analysis of coronavirus outbreak across industries to help you prepare for the future.
Click here to get the short-term and long-term impact of COVID-19 on this Market.Please visit: https://www.fortunebusinessinsights.com/industry-reports/nebulizers-market-100707
Regional AnalysisStrong Healthcare Infrastructure to Support Market Growth in North AmericaNorth America boasted a market size of USD 308.4 million in 2019 and the region is likely to lead the Nebulizer market share during the forecast period. This is chiefly attributable to the presence of a robust healthcare infrastructure and patient-friendly reimbursement policies.In addition to this, escalating number of COVID-19 cases in the US will skyrocket the demand for Nebulizer and inhalers in 2020. Similar trends are expected to be observed in Europe. On the other hand, the market is Asia-Pacific is slated for steady expansion owing to the proliferation of medical device companies and rising prevalence of chronic respiratory disorders.Competitive LandscapeKey Players to Focus on Launching Innovative ProductsCompetition in this market is dominated by the presence of a few large companies, who are engaged in developing novel products to cater to the changing needs and demands of patients. The smaller players are strengthening their finances and exploring new avenues to establish themselves in this market.
Quick Buy –  Nebulizer Market Research Report: https://www.fortunebusinessinsights.com/checkout-page/100707
Industry Developments:October 2018: Philips introduced its lightest and smallest portable on-the-go nebulizer, InnoSpire Go, in North America. The innovative solution delivers medication quickly and accurately, reduces treatment time by 25%, operates silently, and has hospital-grade features.March 2018: The US-based medical technology company, Convexity Scientific, launched its portable, silent, and next-gen nebulizer FLYP. Featuring an all-in-one design, the device can be used at home or in outside healthcare facilities to treat chronic pulmonary disorders such as asthma effectively.
List of Key Players Covered in this Nebulizer Market Report:Teleflex Medical, Inc.Trudell Medical InternationalBriggs HealthcarePARI Respiratory Equipment, Inc.Omron Healthcare, Inc.Allied Healthcare Products, Inc.GF HEALTH PRODUCTS, INC.DeVilbiss Healthcare LLCKoninklijke Philips N.V.
Have Any Query? Ask Our Experts: https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/nebulizers-market-100707
Nebulizer Market Segmentations:By Type•              Jet Nebulizer•              Ultrasonic Nebulizer•              Mesh NebulizerBy Modality•              Portable•              Table-topBy End user•              Hospitals•              Clinics•              Homecare SettingsBy Geography•              North America (U.S. and Canada)•              Europe (U.K., Germany, France, Italy, Spain, Scandinavia, and Rest of Europe)•              Asia-Pacific (Japan, China, India, Australia, Southeast Asia, and Rest of Asia- Pacific)•              Latin America (Brazil, Mexico, and Rest of Latin America)•              Middle East & Africa (GCC, South Africa, and Rest of Middle East & Africa)
Get your Customized Research Report: https://www.fortunebusinessinsights.com/enquiry/customization/nebulizers-market-100707
Have a Look at Related Reports:Sleep Apnea Devices Market Share & Covid-19 Impact Analysis, By Device Type (Therapeutic Devices, and Diagnostic Devices), By End User (Sleep Laboratories & Clinics, and Homecare & Other Settings), and Regional Forecast, 2020-2027Nasal Drug Delivery Market Share and Industry Analysis, By Type (Dry Powder Inhalers (DPIs), Metered Dose Inhalers (MDIs), and Nebulizers), By Application (Asthma, Chronic Obstructive Pulmonary Disease (COPD), and Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies) and Geography Forecast till 2026Drug Delivery Market Share & Industry Analysis, By Route of Administration (Injectable, Nasal, Topical & Transdermal, Oral and Others), By Type (Conventional and Advanced), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies) and Regional Forecast, 2019-2026Continuous Renal Replacement Therapy (CRRT) Market Share & Industry Analysis, By Product (Systems, and Consumables), By Modality (Slow Continuous Ultra-Filtration {SCUF}, Continuous Venovenous Hemofiltration {CVVH}, Continuous Venovenous Hemodialysis {CVVHD}, and Continuous Venovenous Hemodiafiltration {CVVHDF}), and Regional Forecast, 2019-2026Contraceptive Devices Market Share and Global Trend By Product Type (Male & Female Contraceptive Devices, Technology (Hormonal & Barrier Contraceptives), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Clinics, Online Channels, Public Channel & NGO & Others) and Geography Forecast till 2025
About Us:Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.At Fortune Business Insights™ we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.
Contact Us:Fortune Business Insights™ Pvt. Ltd.
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune-Bangalore Highway,
Pune – 411045, Maharashtra, India.
Phone:
US :+1 424 253 0390
UK : +44 2071 939123
APAC : +91 744 740 1245
Email: sales@fortunebusinessinsights.com
Fortune Business Insights™
LinkedIn | Twitter | Blogs

Press Release: https://www.fortunebusinessinsights.com/press-release/nebulizer-market-9958

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.